Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Alan Meds vs HealthSource

Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, HealthSource a 79. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Alan Meds

#7 · Grade A · Best Value

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full Alan Meds review →
VS

HealthSource

#75 · Grade B · Fair Price

Est. first month

From $199/mo (all doses, compounded)

Save ~85% vs brand-name
Get this deal Full HealthSource review →

The verdict

Better value: Alan Meds

Alan Meds takes it on Value Score, 90 to 79 an est. $99/mo first month, with no teaser step-up baked in. HealthSource isn't out of it: Shoppers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealAlan MedsHealthSource
Value Score90 (A)79 (B)
Est. first month$99/moFrom $199/mo (all doses, compounded)
Save vs brand-name~93%~85%
Semaglutide$99/moFrom $199/mo (all doses, compounded)
Tirzepatide$145/moFrom $299/mo (all doses, compounded)
Both moleculesYesYes
PricingFlat — no step-upFlat — no step-up
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
72
Alan Meds: 95. HealthSource: 72.
85
No Teaser-Rate Bait
90
Alan Meds: 85. HealthSource: 90.
98
Nationwide Availability
96
Alan Meds: 98. HealthSource: 96.
94
Both Molecules
98
Alan Meds: 94. HealthSource: 98.
82
Easy Cancellation
58
Alan Meds: 82. HealthSource: 58.
72
Reputation
63
Alan Meds: 72. HealthSource: 63.

Alan Meds

Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.

Why it's a deal

  • $99 flat semaglutide and a low $145 tirzepatide
  • Available in all 50 states
  • Offers an oral/sublingual route

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Newer operator with a thin public track record

HealthSource

HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.

Why it's a deal

  • Three GLP-1 options: compounded semaglutide injection, tirzepatide injection, and oral sublingual tirzepatide
  • 24/7 access to care team via HIPAA-compliant platform with unlimited physician messaging
  • Every program covers the cost of medication, supplies, and telehealth visits — no separate pharmacy fee
  • Subscription auto-refund if monthly reassessment is not completed
  • Available in all 50 US states including Alaska and Hawaii with 3–5 day shipping

The fine print

  • No physician names or clinical leadership disclosed on public pages
  • No LegitScript certification found
  • 503A partner pharmacy not named — less transparent than providers disclosing their 503B pharmacy
  • Labs not mentioned on any product page — baseline bloodwork protocol unknown
  • WooCommerce e-commerce storefront may feel more transactional than clinical
Get the Alan Meds deal Get the HealthSource deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Alan Meds is ranked on the Alan Meds alternatives board, and the same list for the other side is on alternatives to HealthSource.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.